The United States Food and Drug Administration (USFDA) approves Zydus Lifescience for Empagliflozin and Metformin Hydrochloride Tablets in 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg.

• Key Factors Behind Today’s Market Rally
• HDFC Bank Shares Climb 3% on Strong Q1 Update
• Overnight Stock Market Movements: Key Developments 
• Stocks Under F&O Ban 
• Indian Hume Pipe Soars 9% on Rs 738 Cr Rajasthan Order

These tablets are used for proper diet and exercise, which improves glycemic control in adults with two types of diabetes mellitus.

Also, they are used to lower the risk of cardiovascular disease. In India, only Ahmedabad will be manufactured at the formulation facility at SEZ.